As healthcare providers and institutions switch to a value based care system, how will healthcare and life science innovators navigate this paradigm shift? Will your new therapeutic/device/diagnostic be groundbreaking enough to be worthy of procurement in a risk sharing environment? How will you change your reimbursement strategies during the development process?
Come and learn about MIPS, APM, MACRA and a whole host of new acronyms for your glossary!
Share your story as to why you think your innovation is well poised for the value based program.
Jeffrey N. Hausfeld MD, MBA
Chairman and Founder - SoPE
Chairman of the Board and Chief Medical Officer - BioFactura Inc
Jerome Canady, M.D.
Co-Founder, CEO, and Chief Science Officer for US Medical Innovations
Jerome Canady, M.D. has over 24 years of experience in the experimental and clinical application of surgical plasma and is currently the Co-Founder, CEO, and Chief Science Officer for US Medical Innovations, LLC and its family of companies that provide revolutionary hybrid plasma electrosurgical scalpels, endoprobes, and generators. As a surgical resident at the University of Pittsburgh Medical Center (UPMC) in 1993, he invented and patented the world’s first flexible endoscopic application for Argon Plasma Coagulation, which provides the basis for the entire sub-field today. He completed his General Surgery residency at UPMC, a post-doctoral Fellowship in Immunology and Clinical Fellowship in Organ Transplantation at the Yale University School of Medicine/Yale New Haven Hospital, and an Advanced Fellowship for Multivisceral & Intestinal Transplantation in Adults and Children at UPMC’s, Thomas E. Starzl Transplantation Institute and Children’s Hospital of Pittsburgh, and serves as a diplomate of the American Board of Surgery and certified by the American Society of Transplant Surgeons.
Tuesday William, President, 2SDAY International, LLC (email@example.com)
2SDAY International, LLC was formed in 2012 by Tuesday A. Williams after a successful career in the biopharmaceutical industry. Ms. Williams spent sixteen-years with a Fortune 500 healthcare company, her area of expertise is healthcare policy and reimbursement. Prior to joining the biopharmaceutical industry, Ms. Williams worked at a healthcare consulting firm providing billing, coding, coverage, patient assistance, policy, and reimbursement guidance to healthcare providers in the continental United States. 2SDAY International is the springboard that has propelled Ms. Williams to utilize her twenty-years of healthcare experience to create her own consulting firm.
The company, based in Baltimore, MD, provides innovative global healthcare consulting solutions to public and private insurance agencies. 2SDAY International consulting firm provides subject matter experts on complex technical government and commercial policy and reimbursement regulations, including the Affordable Care Act
Victor Grazette PhD, EMBA - Senior Leader/Administrator for Chronic Care/Corporate Director at Dimensions Healthcare System in Maryland
Areas of responsibility: Primary administrative and clinical responsibilities are focused on operations, planning, program growth, building optimized teams, architecting employee engagement and developing infrastructures that support the clinical and business objectives of the organization; Measuring, monitoring, mitigating and reporting organizational labor utilization, readmissions and denials.
Responsibilities across the system requires innovation, collaboration, creating and managing standardization across the organization, considering culture differences between sites; paying close attention to nuances and adjusting leadership-style and communication accordingly.